The ‘marker of proliferation Ki-67’ (MKI67) and ‘proliferating cell nuclear antigen’ (PCNA) are clinically important indicators commonly used to assess tumor cell proliferation, as well as the degree of malignancy and prognosis [23,24,25]. Here, PCNA is linked to neoplasm.